Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.
Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.
ASCO 2020
🚨 24 hours until #ESMOAsia23 🚨
Make sure to stay tuned for the congress – follow us @VJOncology and head to http://VJOncology.com for exciting developments
@myESMO #Oncology #ImmunoOnc
🎥Jolanta Kunikowska of @UniWarszawski discusses the importance of genotype in accurate diagnosis and treatment of paragangliomas/pheochromocytomas:
➡️⬅️
@myESMO #ESMO23 #hncSM
The importance of genotype in accurate diagnosis and treatment of paragangliomas/ pheochromocytomas
Jolanta Kunikowska, MD, PhD, Medical University of Warsaw, Warsaw, Poland, discusses the observation of genotype in th...
ow.ly
November is #LungCancer Awareness month 🫁 📣
Check out this NEW VJSessions episode: #CTscreening for patients with #lungcancer in the UK with @BTOGORG 💬 🇬🇧
With David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair ⬇️
https://ow.ly/yozx50Q5n7H
#LCsm
🎥@RobinL_Jones from @ICR_London shares his highlights in sarcoma from #ESMO23:
➡️⬅️
@myESMO #scmSM
Highlights in sarcoma at ESMO 2023
Robin L. Jones, MBBS, MRCP, MD, Institute of Cancer Research in London, highlights key sessions in sarcoma at the ...
ow.ly
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
➡️⬅️
#PancSM #CRCSM #ImmunoOnc #CTSM
How much progress have we made in targeting KRAS in GI malignancies?
Benedikt Westphalen, MD, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany, discusses advances in targeting KRAS. ...
ow.ly
ASCO 2020
The American Society of Oncology (ASCO) 2020 Annual Meeting was held virtually this year due to the ongoing COVID-19 pandemic. Although the meeting was virtual, the programme was full of the latest data, ongoing controversies in the field and updates on potential new treatments for cancer.
Hot topics at this year’s meeting included immunotherapy, COVID-19 and cancer, developmental therapeutics and care delivery. Data were presented from the latest clinical trials including ADAURA, JAVELIN , E2108 and KEYNOTE-177.
🚨 24 hours until #ESMOAsia23 🚨
Make sure to stay tuned for the congress – follow us @VJOncology and head to http://VJOncology.com for exciting developments
@myESMO #Oncology #ImmunoOnc
🎥Jolanta Kunikowska of @UniWarszawski discusses the importance of genotype in accurate diagnosis and treatment of paragangliomas/pheochromocytomas:
➡️⬅️
@myESMO #ESMO23 #hncSM
The importance of genotype in accurate diagnosis and treatment of paragangliomas/ pheochromocytomas
Jolanta Kunikowska, MD, PhD, Medical University of Warsaw, Warsaw, Poland, discusses the observation of genotype in th...
ow.ly
November is #LungCancer Awareness month 🫁 📣
Check out this NEW VJSessions episode: #CTscreening for patients with #lungcancer in the UK with @BTOGORG 💬 🇬🇧
With David Baldwin, Beth Sage, Phillip Crosbie, Matthew Callister and Arjun Nair ⬇️
https://ow.ly/yozx50Q5n7H
#LCsm
🎥@RobinL_Jones from @ICR_London shares his highlights in sarcoma from #ESMO23:
➡️⬅️
@myESMO #scmSM
Highlights in sarcoma at ESMO 2023
Robin L. Jones, MBBS, MRCP, MD, Institute of Cancer Research in London, highlights key sessions in sarcoma at the ...
ow.ly
🎥@BenWestphalen of @LMU_Muenchen highlights the transformative impact of KRAS inhibitors, like sotorasib and panitumumab, across oncology, with significant advancements discussed at #ESMO23:
➡️⬅️
#PancSM #CRCSM #ImmunoOnc #CTSM
How much progress have we made in targeting KRAS in GI malignancies?
Benedikt Westphalen, MD, Ludwig-Maximilians-University (LMU) Hospital, Munich, Germany, discusses advances in targeting KRAS. ...
ow.ly
